Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Concentrix CorpCNXC · Entity 4519 | Director | March 25, 2025 | March 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Concentrix Corp
Report date March 25, 2025 · Filed March 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,826 |
Reported balance
After 2025-03-25 transaction · row 1
1 source rowRow 1 · 2025-03-25 · Grant · Acquired 3,873 · Balance 7,826 F1: Represents restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2026 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2026 Annual Meeting of Stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2025 Filed Mar 27, 2025 20:23 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 3,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-25-000090 · wk-form4_1743107029.xml · nonDerivative · entry 1 Gheysens Nicolas · CIK 0001993116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,826 F1 · kind: Represents restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2026 Annual Meeting of Stockholders. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 22:01 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 2,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-24-000093 · wk-form4_1711144878.xml · nonDerivative · entry 1 Gheysens Nicolas · CIK 0001993116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,953 F1 · kind: Represents restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| September 25, 2023 Filed Sep 28, 2023 00:59 UTC | Concentrix Corp CNXC · Entity 4519 | GrantCommon Stock | 1,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001803599-23-000204 · wk-form4_1695862759.xml · nonDerivative · entry 1 Gheysens Nicolas · CIK 0001993116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,173 F1 · shares: Represents restricted stock units under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the date of the Issuer's 2024 Annual Meeting of Shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.